Scott G. Davis - 10 Nov 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
CEO, Director
Signature
/s/ Jerome Wong
Issuer symbol
EKSO
Transactions as of
10 Nov 2025
Net transactions value
-$111,912
Form type
4
Filing time
12 Nov 2025, 17:04:28 UTC
Previous filing
07 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Scott G. Davis filed Form 4 for EKSO BIONICS HOLDINGS, INC. (EKSO) on 12 Nov 2025."

Quick Takeaways

  • This page summarizes Scott G. Davis's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 12 Nov 2025, 17:04.

What Changed

  • Previous filing in this sequence was filed on 07 Nov 2025.
  • Current net transaction value: -$111,912.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Scott G. CEO, Director 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong 12 Nov 2025 0001908860

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Sale $111,912 -23,315 -23% $4.80 78,777 10 Nov 2025 Direct F1, F2, F3
holding EKSO Common Stock 373 10 Nov 2025 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Reporting Person on November 10, 2025 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in Form 4 filed with the Commission on November 7, 2025.
F2 These shares were sold in a single transaction at a price of $4.7990 per share.
F3 On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Sponsored